D'AMBROSI, NADIA
 Distribuzione geografica
Continente #
NA - Nord America 8.835
AS - Asia 1.787
EU - Europa 1.401
SA - Sud America 288
AF - Africa 45
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.370
Nazione #
US - Stati Uniti d'America 8.763
SG - Singapore 799
CN - Cina 319
IT - Italia 308
RU - Federazione Russa 269
BR - Brasile 241
HK - Hong Kong 215
DE - Germania 171
VN - Vietnam 142
IE - Irlanda 116
UA - Ucraina 90
GB - Regno Unito 89
JP - Giappone 84
FR - Francia 68
SE - Svezia 66
FI - Finlandia 63
BD - Bangladesh 62
CA - Canada 50
PL - Polonia 47
IN - India 40
KR - Corea 27
NL - Olanda 27
ES - Italia 22
ID - Indonesia 22
AR - Argentina 16
CZ - Repubblica Ceca 16
IQ - Iraq 14
ZA - Sudafrica 12
TR - Turchia 11
AU - Australia 10
CI - Costa d'Avorio 10
EC - Ecuador 10
MX - Messico 10
PK - Pakistan 9
IL - Israele 8
AT - Austria 6
EG - Egitto 6
UZ - Uzbekistan 6
CH - Svizzera 5
GR - Grecia 5
JM - Giamaica 5
LT - Lituania 5
PY - Paraguay 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CO - Colombia 4
DK - Danimarca 4
KE - Kenya 4
MY - Malesia 4
PT - Portogallo 4
JO - Giordania 3
KZ - Kazakistan 3
NG - Nigeria 3
NO - Norvegia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
AL - Albania 2
CL - Cile 2
HR - Croazia 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
NR - Nauru 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 12.370
Città #
Woodbridge 1.993
Houston 1.654
Wilmington 1.621
Singapore 480
Fairfield 402
Ashburn 363
San Jose 239
Hong Kong 214
Chandler 191
Ann Arbor 187
Seattle 179
Beijing 132
Cambridge 127
Dublin 110
New York 100
Rome 92
Santa Clara 84
Medford 83
Jacksonville 80
The Dalles 80
Los Angeles 79
Munich 64
Council Bluffs 63
Tokyo 61
Ho Chi Minh City 46
Buffalo 40
Lawrence 40
Dearborn 39
Moscow 39
Dallas 37
Hanoi 36
Helsinki 29
Lauterbourg 29
Kraków 27
São Paulo 26
London 22
Falls Church 19
Milan 19
Denver 18
San Diego 18
Montreal 16
Warsaw 16
Pune 15
Toronto 14
Chicago 13
Frankfurt am Main 13
Phoenix 13
Atlanta 12
Brooklyn 12
Mülheim 12
North Bergen 12
Orem 12
Poplar 12
Turku 12
Amsterdam 11
Brno 11
Jakarta 11
Abidjan 10
Charlotte 10
Nuremberg 10
Stockholm 10
Columbia 9
Menlo Park 9
Mountain View 9
Norwalk 9
Salt Lake City 9
Shenzhen 9
Brasília 8
Johannesburg 8
Ankara 7
Boston 7
Naples 7
Redondo Beach 7
Seoul 7
Amagasaki 6
Lappeenranta 6
Leeds 6
Miami 6
Pittsburgh 6
Rio de Janeiro 6
San Francisco 6
San Mateo 6
Zibo 6
Belo Horizonte 5
Boardman 5
Bologna 5
Campinas 5
Chennai 5
City of London 5
Da Nang 5
Del Norte 5
Haiphong 5
Ottawa 5
Piscataway 5
Redwood City 5
Rostock 5
Shanghai 5
St Louis 5
Sydney 5
Verona 5
Totale 9.663
Nome #
Copper at synapse: Release, binding and modulation of neurotransmission 518
Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons 490
Up-regulation of P2X(2), P2X(4) receptor and ischemic cell death: Prevention by P2 antagonists 483
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. 473
2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines 461
ALS: focus on purinergic signalling 460
Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue 456
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis 442
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATP 437
2-ClATP exerts anti-tumoural actions not mediated by P2 receptors in neuronal and glial cell lines 431
Pathways to mitochondrial dysfunction in ALS pathogenesis 426
P2 receptor modulation and cytotoxic function in cultured CNS neurons 411
Differences in the neurotoxicity profile induced by ATP and ATP gamma S in cultured cerebellar granule neurons 396
The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells 374
Overexpression of superoxide dismutase 1 protects against beta-amyloid peptide toxicity: effect of estrogen and copper chelators 361
The S100B story: from biomarker to active factor in neural injury 361
Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists 343
Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys)Regulation 310
Differential toxicity of TAR DNA-binding protein 43 isoforms depends on their submitochondrial localization in neuronal cells 254
UsnRNP trafficking is regulated by stress granules and compromised by mutant ALS proteins 212
The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis 203
Rac1 at the crossroad of actin dynamics and neuroinflammation in Amyotrophic Lateral Sclerosis 177
Ablation of p2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis 165
Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation 163
The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches 150
Commentary: multifactoriality of amytrophic lateral sclerosis: linking unfolded proteins to oxidative stress in microglia 149
Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis 147
Purinergic signaling: A common pathway for neural and mesenchymal stem cell maintenance and differentiation 145
Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis 142
The Astrocytic S100B Protein with Its Receptor RAGE Is Aberrantly Expressed in SOD1G93AModels, and Its Inhibition Decreases the Expression of Proinflammatory Genes 134
Lipid catabolism and mitochondrial uncoupling are stimulated in brown adipose tissue of amyotrophic lateral sclerosis mouse models 120
COntribution of S100A4-regulated pathways to inflammation in ALS models 117
UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor 113
Frataxin deficiency shifts metabolism to promote reactive microglia via glucose catabolism 105
Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models 97
Purinergic signalling at the plasma membrane: A multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis 94
Fibrotic Scar in Neurodegenerative Diseases 92
N-acetylaspartate mitigates pro-inflammatory responses in microglial cells by intersecting lipid metabolism and acetylation processes. 92
Cytoplasmic accumulation of a splice variant of hnRNPA2/B1 contributes to FUS-associated toxicity in a mouse model of ALS 91
Loss of homeostatic functions in microglia from a murine model of Friedreich's ataxia 85
Fibrosis as a common trait in amyotrophic lateral sclerosis tissues 84
Antagonists of P2 receptor prevent NGF-dependent neuritogenesis in PC12 cells 83
The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells 81
The Contribution of Non-Neuronal Cells in Neurodegeneration: From Molecular Pathogenesis to Therapeutic Challenges 80
P2 receptor web: complexity and fine-tuning 76
Extracellular ATP and neurodegeneration 76
Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems 75
C9orf72 Toxic Species Affect ArfGAP-1 Function 73
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models 73
Niclosamide Targets Inflammatory and Profibrotic Pathways in Amyotrophic Lateral Sclerosis 72
S100A4 in the Physiology and Pathology of the Central and Peripheral Nervous System 72
Receptor webs: can the chunking theory tell us more about it? 67
Targeting S100A4 to study the macrophages-muscle cells cross-talk in models of Duchenne Muscular Dystrophy 64
Metabotropic purinergic receptors in lipid membrane microdomains 64
Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia 63
P2 receptors in human heart: upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death 61
Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors 60
Neuroinflammation in Friedreich's Ataxia 60
CYTOPLASMIC AGGREGATION OF WT TDP-43 AND FUS P525L CAUSES GENOME DAMAGE IN A CELLULAR MODEL SYSTEM OF ALS 58
Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones 58
Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells 57
Targeting S100A4 to improve inflammation and fibrosis in Duchenne Muscular Dystrophy 56
Protein cooperation: from neurons to networks 54
Do ATP and NO interact in the CNS? 53
Inflammation in the CNS and PNS: From Molecular Basis to Therapy 50
Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters 47
Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation 44
Biochemical dissection of STAT3 signaling in amyotrophic lateral sclerosis 42
Repurposing niclosamide for the treatment of neurological disorders 39
Niclosamide reprograms macrophages and improves muscle integrity in Duchenne muscular dystrophy models 34
Targeting S100A4 to modulate inflammation and improve muscle regeneration in Duchenne muscular dystrophy 20
Repurposing niclosamide to target inflammatory and fibrotic pathways to affect ALS 19
Niclosamide ameliorates disease progression in models of amyotrophic lateral sclerosis 18
PATHOGENIC FUS PROMOTES THE EXPRESSION OF AGGREGATION-PRONE SPLICING ISOFORMS OF HNRNPA2B1 IN AMYOTROPHIC LATERAL SCLEROSIS 17
Totale 12.630
Categoria #
all - tutte 41.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 17 48 14 21 17 43 22 11 54 25 28 118
2022/2023579 45 42 8 55 57 120 46 26 60 2 33 85
2023/2024267 29 7 22 11 47 90 15 3 5 8 7 23
2024/20251.395 55 296 132 94 12 117 162 56 80 85 127 179
2025/20263.039 261 135 302 323 246 118 330 388 329 274 201 132
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 12.630